245 related articles for article (PubMed ID: 848799)
21. Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.
Pomer S; Sarai K; Krause E; Satter P
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):602-7. PubMed ID: 6437993
[TBL] [Abstract][Full Text] [Related]
22. Aortic input impedance during nitroprusside infusion. A reconsideration of afterload reduction and beneficial action.
Pepine CJ; Nichols WW; Curry RC; Conti CR
J Clin Invest; 1979 Aug; 64(2):643-54. PubMed ID: 457874
[TBL] [Abstract][Full Text] [Related]
23. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Mehta J; Iacona M; Pepine CJ; Conti CR
Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
[TBL] [Abstract][Full Text] [Related]
24. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
[No Abstract] [Full Text] [Related]
25. Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
Am J Cardiol; 1981 Nov; 48(5):939-46. PubMed ID: 7304442
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade.
Fowler NO; Gabel M; Holmes JC
Circulation; 1978 Mar; 57(3):563-7. PubMed ID: 624165
[TBL] [Abstract][Full Text] [Related]
27. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
Packer M; Meller J; Gorlin R; Herman MV
Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769
[TBL] [Abstract][Full Text] [Related]
28. Continuous hydralazine infusion for afterload reduction.
Swartz MT; Kaiser GC; Willman VL; Codd JE; Tyras DH; Barner HB
Ann Thorac Surg; 1981 Aug; 32(2):188-92. PubMed ID: 7259359
[TBL] [Abstract][Full Text] [Related]
29. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
Rubin LJ; Handel F; Peter RH
Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
Franciosa JA; Cohn JN
Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
[TBL] [Abstract][Full Text] [Related]
31. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
Kittleson MD; Johnson LE; Oliver NB
J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
[TBL] [Abstract][Full Text] [Related]
32. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
[No Abstract] [Full Text] [Related]
33. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
Stemple DR; Kleiman JH; Harrison DC
Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
[TBL] [Abstract][Full Text] [Related]
34. Hydralazine in the management of left ventricular failure.
Fitchett DH; Neto JA; Oakley CM; Goodwin JF
Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
[No Abstract] [Full Text] [Related]
35. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
36. Effects of the automated management of hypertension after open heart surgery. The relevance of the initial systemic vascular resistance as index for predicting hemodynamic response to computer-controlled nitroprusside infusion.
Pomer S; Elert O; Satter P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):207-13. PubMed ID: 6715091
[TBL] [Abstract][Full Text] [Related]
37. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
Sladen RN; Rosenthal MH
J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
[TBL] [Abstract][Full Text] [Related]
38. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of nitroprusside infusion during coronary artery operation in man.
Lappas DG; Lowenstein E; Waller J; Fahmy NR; Daggett WM
Circulation; 1976 Dec; 54(6 Suppl):III4-10. PubMed ID: 991424
[TBL] [Abstract][Full Text] [Related]
40. The hemodynamic response to dopamine and nitroprusside following right atrium-pulmonary artery bypass (Fontan procedure).
Williams DB; Kiernan PD; Schaff HV; Marsh HM; Danielson GK
Ann Thorac Surg; 1982 Jul; 34(1):51-7. PubMed ID: 7092400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
